Overview and Scope
Interferons refer to a natural substance that supports the body’s immune system in the battle against illness, including cancer. White blood cells and other cells in the body produce interferons, but they can also be produced in a lab for use in treating various disorders.
Sizing and Forecast
The interferons market size has grown steadily in recent years. It will grow from $9.17 billion in 2023 to $9.54 billion in 2024 at a compound annual growth rate (CAGR) of 4.0%. The growth in the historic period can be attributed to viral infections, antiviral therapies, cancer treatment, autoimmune diseases.
The interferons market size is expected to see steadily grown in the next few years. It will grow to $11.98 billion in 2028 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to immunotherapy advancements, precision medicine, viral outbreak preparedness, drug combinations, gene therapy. Major trends in the forecast period include expanding applications, biopharmaceutical innovation, interferon combinations, personalized medicine.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/interferon-global-market-report
Segmentation & Regional Insights
The interferons market covered in this report is segmented –
1) By Type: Inteferon Alpha, Inteferon Beta, Inteferon Gamma
2) By Application: Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, Renal Cell Carcinoma
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies, Other Distribution Channels
North America was the largest region in the interferons market in 2023. Middle East is expected to be the fastest-growing region in the interferons market during the forecast period. The regions covered in the interferons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=2836&type=smp
Major Driver Impacting Market Growth
The rise in cancer is expected to boost the growth of the interferon market going forward. Cancer is a group of diseases characterized by the development of abnormal cells that divide uncontrollably and have the ability to spread to other parts of the body. Interferons are used in the treatment of various types of cancer, including melanoma, Kaposi’s sarcoma, and certain leukemias. They are often included in combination therapies, helping to boost the body’s immune response against cancer cells. For instance, in January 2022, according to a report published by the American Cancer Society, a US-based health organization, in the US, 609,360 cancer deaths and 1.9 million new cancer cases are anticipated in 2022. There are expected to be 10,470 pediatric cancer cases in 2022. Additionally, 5,480 teenagers are anticipated to have cancer diagnoses in 2022. Therefore, the rise in cancer is driving the growth of the interferon market.
Key Industry Players
Major companies operating in the interferons market include Roche Holding AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Biogen Inc., Bayer AG, Zydus Cadila Health Care Limited, Novartis AG, Pfizer Inc., Biosidus S.A., Nanogen Biopharmaceutical Co. Ltd., Amega Biotech Inc., Rhein Minapharm Biogenetics S.A.E., PROBIOMED S.A. de C.V., Schering-Plough Corporation, 3SBio Inc., AbbVie Inc., Celgene Corporation, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Genentech Inc., GlaxoSmithKline PLC, Johnson & Johnson, Novo Nordisk A/S, Sanofi S.A., Shire PLC, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Biocad, Cipla Limited, Dr. Reddy’s Laboratories Ltd., Hetero Drugs Limited
The interferons market report table of contents includes:
1. Executive Summary
2. Interferons Market Characteristics
3. Interferons Market Trends And Strategies
4. Interferons Market – Macro Economic Scenario
5. Global Interferons Market Size and Growth
.
.
.
31. Global Interferons Market Competitive Benchmarking
32. Global Interferons Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Interferons Market
34. Interferons Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Myocardial infarction is a potentially fatal disorder that develops when the heart…
A mid- and high-level precision GPS receiver, also known as a survey-grade GPS receiver, is…
Overview and Scope Pharmaceutical continuous manufacturing (PCM) is a process of producing pharmaceutical goods from…
Overview and Scope Neuroendocrine tumor treatment refers to the process of medical interventions and therapies…
Overview and Scope OTC drugs refer to pharmaceuticals that are available over the counter and…
A microscope is a scientific instrument used to magnify and observe objects or specimens that…